PATENT
False detachment: When gurus cling to opinions
Humans have created systems of ownership through the value placed on 'MINE', leading to claims over land, people, and ideas. Philosophers and gurus discussing detachment and subjective versus objective truths reflect societal conflicts in balancing wealth, power, and property rights.
Indian generic drugs linked to deaths in US? Trade group slams study blaming desi pharma
A study found Indian generics sold in the US between 2009-2018 linked to a 54% higher risk of serious side effects compared to domestic drugs. The findings have drawn criticism from the Indian Pharmaceutical Alliance, which disputes the study’s methodology and its implications on quality and efficacy.
Stock market dream 11: William O'Neil picks its portfolio champions for all seasons
Mayuresh Joshi of William O'Neil India puts forth a list of 11 stocks, inspired by the India Champions Trophy-winning team, that demonstrate diverse qualities such as aggressiveness, stability, and an X-factor. These stocks include prominent names like Avanti Feeds, Bajaj Finance, and Narayana Hrudayalaya, suitable for various market conditions and showcasing strong potential for performance.
Govt disputes UPA patent on Food Security Act in Lok Sabha
The government claimed that the UPA did not effectively implement the Food Security Act, which was introduced in 2013, and credited PM Narendra Modi with systematically providing free food grains to 800 million people. Additionally, the 'One Nation, One Ration Card' scheme assists migrant workers in availing food grains nationwide.
New affordable diabetes drug Empagliflozin launched in India
Several domestic drug makers, including Mankind Pharma, have launched the diabetes drug Empagliflozin at significantly reduced prices following the expiration of Boehringer Ingelheim’s patent. Mankind Pharma’s version is priced at Rs 5.50 per tablet, a reduction of 90%. This move is expected to improve access to affordable diabetes treatment in India.
Is Meghan Markle’s 'As Ever' rebrand a desperate bid to stay relevant? Insiders call it her ‘final gamble'
Meghan Markle rebrands her struggling lifestyle venture from American Riviera Orchard to As Ever, launching a new Instagram-focused PR campaign. Critics see this as a desperate attempt to salvage the project before her upcoming Netflix show, With Love, Meghan. With failed projects and canceled deals, Markle is under immense pressure to deliver success.
- Go To Page 1
9 stocks from the chemicals sector which can give more than 18% return in 1 year, according to analysts
Check out Stock Reports Plus, powered by Refinitiv, for price targets of over 4,000 listed stocks along with detailed company analysis focusing on five key components – earnings, fundamentals, relative valuation, risk, and price momentum – to generate standardized scores. SR+ Reports is a complimentary offering to ETPrime members.
AWS APJ chief technologist to leave hyperscaler, third leadership change in two years
Shalini Kapoor, currently serving as chief technologist for the Asia Pacific & Japan (APJ) region at Amazon Web Services (AWS), is set to depart from the tech giant to join the Bengaluru-based people+ai, a company backed by Nandan Nilekani. Kapoor has been actively volunteering with the EkStep Foundation, which is behind the people+ai initiative.
Indian pharma cos to launch cheaper diabetes medicine at 90% lower price soon
Domestic drug companies in India are preparing to launch affordable generics of the diabetes drug Empagliflozin after the expiry of Boehringer Ingelheim's patent on March 11. This will make diabetes therapy more accessible and cost-effective for millions of people. Companies like Mankind Pharma, Torrent, Alkem, Dr Reddy's, and Lupin will offer Empagliflozin at significantly lower prices.
US push for grand trade agreement; opening agri sector: An explainer
The US is urging India to negotiate a comprehensive trade agreement, with a key focus on opening India's agriculture sector. This would involve reducing import tariffs, potentially impacting 700 million rural livelihoods. India currently imposes tariffs ranging from zero to 150% to protect its farmers. US seeks to export heavily subsidised farm products, which India views as sensitive.
Apple defeats AliveCor bid to block US smartwatch imports in US appeal
The US Court of Appeals for the Federal Circuit affirmed the invalidity of AliveCor heart-rate monitoring patents that the company had accused Apple of infringing, negating a U.S. trade tribunal's ruling that Apple had violated AliveCor's rights.
India’s EU trade deal faces a costly hurdle due to strict laws
The European Union's stringent environmental regulations pose significant challenges in the ongoing free trade agreement negotiations with India. Issues such as the Carbon Border Adjustment Mechanism and privacy data protection laws could impose additional costs on Indian exports, despite efforts for exemptions or compensatory measures.
'Shark Tank India 4': Vineeta Singh gets impressed with shock-giving gloves that protect women, tells founders, 'We give crores here ...'
In a Shark Tank India episode, Karnataka founders introduced gloves designed to protect women, featuring alarms, GPS, and a mild electric shock. Despite some panel concerns, they secured funding from Aman Gupta and Vineeta Singh. The personal safety device aims to enhance women's protection in dangerous situations.
Race against April 2 deadline: For US tariff truce, government mulls 2-pronged strategy
India is assessing its import basket to create a customized lower tariff structure for the US, considering sectors like agriculture and automobiles. Negotiations for a bilateral trade agreement are advancing, with an emphasis on reducing tariffs and deepening supply chain integration. Experts urge caution, particularly regarding agriculture and technology-led manufacturing, to protect sensitive sectors.
India should withdraw from all negotiations with US; engage with them likeother countries: GTRI
India should withdraw from trade negotiations with the US and adopt a firm stance similar to countries like China and Canada. Economic think tank GTRI warns against yielding to US trade demands, advising India to counter misinformation and avoid concessions in sensitive sectors, particularly agriculture.
Skoda Auto VW in talks with JSW & Tata Motors for e-car deal
Skoda Auto Volkswagen India is negotiating with JSW Group and Tata Motors for licensing agreements to manufacture electric cars. Talks with Mahindra & Mahindra remain unresolved. The company seeks cost savings and compliance with India's fuel efficiency norms. A deal could help Skoda VW locally produce EVs sooner, avoiding substantial self-funding investments.
Oxford blog praising Karnataka model of development written by person worked at CMO: BJP
The Karnataka model of development, praised by an Oxford blog, is questioned by opposition leader R Ashoka as the blog was authored by a person linked with the Chief Minister's office. Ashoka accused the government of making the Governor spread misinformation and disrespecting the constitutional office.
CAT quashes IRS officer Sameer Wankhede's transfer from Mumbai to Chennai
The Central Administrative Tribunal overturned IRS officer Sameer Wankhede's transfer from Mumbai to Chennai, citing procedural lapses and bias. The tribunal found the revenue department's actions violated their own guidelines and stressed the need for fair and transparent implementation of transfer policies.
Vikram Solar to manufacture solid-state cell and battery
Vikram Solar aims to establish a 1GWh solid-state cell and battery manufacturing facility, scalable up to 5 GWh, to meet global energy demands. Utilizing proprietary technology with majority India-made components, this initiative aligns with India's Atmanirbharta and renewable energy goals, addressing the need for efficient battery storage systems.
Justin Bieber’s long-time personal assistant resigns amid team reshuffle
Justin Bieber's assistant, Mateo Caldas, has quit his team to become an actor. This is just the latest change in Bieber's crew since he has also split with his manager and financial team. Some fans are worried about how the singer has been acting lately. But his representatives have dismissed all rumours.
German court rules Pfizer, BioNTech violated Moderna's COVID-19 vaccine patent
A German court has ruled that Pfizer and BioNTech violated Moderna's COVID-19 vaccine patent. The court in Duesseldorf stated that Pfizer and BioNTech must provide earning details and compensate Moderna. This ruling is subject to appeal, and the specific compensation amount will depend on further proceedings and potential appeals.
China to 'refine' centralized medicine procurement policies
China will refine its centralized drug procurement policy following a probe into off-patent medicine quality, aiming to enhance evaluations and oversight. The healthcare regulator aims to improve pricing mechanisms and support innovative drug development through a medical insurance catalogue, ensuring public confidence in medications remains high.
Sharp re-enters India air-condition market, launches products
Sharp Corporation has announced its return to the Indian air conditioner market, launching three new series designed for extreme weather. The company aims to position itself as a trusted brand in India, integrating its patented Plasmacluster technology to enhance air quality.
Indian exporters may find some solace amid Trump’s tariff heat on China, Mexico & Canada
The imposition of high tariffs by the US on imports from China, Mexico, and Canada opens up opportunities for Indian exporters to increase their presence in the American market. Sectors likely to benefit include agriculture, engineering, machine tools, garments, textiles, chemicals, and leather, making Indian goods more competitive against their counterparts.
DMRC-DAMEPL dispute: Comply with order or face coercive action, SC to DAMEPL, Axis Bank officials
The Supreme Court of India has warned Delhi Airport Metro Express Private Limited (DAMEPL) and Axis Bank of coercive measures if they do not comply with its previous verdict to refund nearly Rs 2,500 crore to DMRC. The legal dispute dates back to 2012, involving a contract termination and arbitration.
Sun Pharma aims to launch anti-obesity and type 2 diabetes drug Utreglutide in five years: Dilip Shanghvi
Sun Pharmaceutical, India's largest drugmaker by revenue, plans to launch its experimental anti-obesity and type 2 diabetes drug Utreglutide in the next four to five years, said Managing Director Dilip Shanghvi. The drug is a GLP-1 receptor agonist and has shown promising results in early trials. Sun Pharma is focusing on launching the drug in India and global markets.
India’s tariffs WTO-compliant, exports to US have low local value add: GTRI
India’s exports to the US include products like iPhones and solar panels with low local value addition, leading to minimal economic gains for India. Think tank GTRI urges the government to ensure the US understands India's WTO-compliant import duties. With upcoming trade talks, India must strategize to avoid escalated trade tensions while explaining its tariff policies.
Indian tariffs are WTO compliant, govt should convey that to US: GTRI
India's import duties align with global trade rules, and the government should communicate this to the US. However, negotiating a free trade agreement with the US poses challenges, including pressure to open government procurement, reduce agricultural subsidies, and alter data flow restrictions, which India continues to resist.
Load More
